semaglutide drug maker Ozempic shortages to last into 2024 as drugmaker urges limit on supplies for weight loss Compounding Novo Nordisk slashes Wegovy

The primary reason is its role as an antioxidant

The treatment attenuated VPA-induced behavioral abnormalities in both Y-maze and social play tests, while also restoring prefrontal SOD and GSH-Px activity and normalizing VPA-related changes in neuronal number and soma size (Margedari et al., 2024)

Angela Tran, Sunlight.coms chief medical advisor

For patients in a maintenance mindset, an oral GLP-1 can offer a lower-burden way to continue treatment with a lighter clinical footprint

As women age, particularly during the perimenopausal transition, they often experience a decline in muscle mass due to hormonal changes and decreased physical activity